The efficacy of first-line chemotherapy is associated with KRAS mutation status in patients with advanced non-small cell lung cancer: a meta-analysis
Crossref DOI link: https://doi.org/10.1007/s12032-015-0489-y
Published Online: 2015-02-08
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhang, Yaxiong
Fang, Wenfeng
Yan, Yue
Wang, Mengyao
Kang, Shiyang
Sheng, Jin
Zhan, Jianhua
Chen, Nan
Hong, Shaodong
Yang, Yunpeng
Ma, Yuxiang
He, Dacheng
Qin, Tao
Zhou, Ting
Tang, Yanna
He, Xiaobo
Liang, Wenhua
Zhang, Li
Text and Data Mining valid from 2015-02-08